The ex-factory price of 15.5 yuan drug ** to sell 213 yuan

A drug with an ex-factory price of 15.5 yuan passed through links between pharmaceutical companies, medical representatives, and doctors. The final price rose to 213 yuan and was sold to patients. The profit reached 1300%. A survey by the reporter found that doctors prescribing drugs profited most during this period. However, in the middle how to allocate, the top-three hospital in Hunan that sells this medicine refused to disclose it.

The patient said that the actual price of 213 yuan was 30 yuan

Ms. Han, who lives in Changsha, received chemotherapy in Xiangya Second Hospital of Hunan Province half a year ago because she had ovarian cancer. After chemotherapy, the doctor advised her to take asparagus tablets with a cancer adjunctive treatment. This kind of asparagus piece was produced by Sichuan Chuanhua West Pharmaceutical Co., Ltd. and the Xiangya Second Hospital had a starting price of 213 yuan per bottle. Ms. Han was found out by inquiring that in fact, this kind of asparagus piece only costs 30 yuan per bottle.

Zhou Hong, the person in charge of drug procurement and the chief pharmacist of Xiangya Second Hospital, the largest tertiary hospital in Hunan Province, told reporters that the price of 213 yuan was set by the state. All drug prices in the hospital were approved by the price department of Hunan Province and were purchased in accordance with regulations.

Zhou Hong introduced that the tender price of asparagus tablets was 185.22 yuan per bottle. "We added 15 points and 213 yuan."

According to China's medical price policy, each drug purchased by the hospital can be sold at a price increase of 15% to patients. The reporter inquired about the guidance price of bidding for pharmaceuticals in Hunan Province in 2010, and found that the guide price for asparagus tablets was 136 yuan. The actual increase rate of Xiangya Second Hospital reached 56%, far exceeding the national regulations of 15%.

The asparagus film sales manager introduced that his company is responsible for buying asparagus pieces from Sichuan Chuandai West Pharmaceutical Co., Ltd. and distributing it to other pharmaceutical companies. These pharmaceutical companies then sell to hospitals through medical representatives who are closely related to the hospital.

The reporter’s sales list obtained from the pharmaceutical company showed that asparagus tablets were sold from medical companies to hospitals, and the price rose from thirty to forty yuan to 136 yuan. The price list of asparagus tablets in storage shows that a bottle of asparagus tablets was purchased from the manufacturer for only 15.5 yuan. In other words, the hospital price is 7 times the wholesale price and 14 times the ex-factory price.

Doctors claim to maximize profits

How to distribute the intermediate profit? Wang Weijun, manager of the Sichuan Office of the Sichuan West China Pharmaceutical Co., Ltd., told reporters that for a profit of 100 yuan, the large hospital gave doctors (deducting) 80 yuan, and the small hospital had less than 80 yuan. According to Wang Weijun, Xiangya No. 2 Hospital has purchased the drug for a monthly profit of more than 100,000 yuan.

In this regard, Xiangya Second Hospital from the hospital procurement of drug managers to prescribe doctors, do not want to talk about rebates.

- Analysis

Hospital Universal Purchasing Quote High Drugs

It is understood that at present, 80% of China's pharmaceutical products are sold through hospitals. Which kind of medicine is used, the hospital has the final say.

Yu Mingde, president of the China Association of Pharmaceutical Enterprise Management, believes that the asparagus ex-factory price of RMB 15.5 is sold at RMB 213. The important reason is that the guidance price for drug bidding is set too high.

"This is an unwritten line of rules and regulations. All the varieties are like this." Yu Mingde exampled, the cephalosporins country priced more than 7 pieces, the most expensive on the market sold 90, most of the top three hospital procurement the latter.

Yu Mingde introduced that when hospitals purchase drugs, they deliberately avoid low-priced drugs, and actively choose high-priced drugs, mainly because some hospitals have drilled a hole in the drug price increase policy.

Non Surgical Lifts

Fei County Mingtao Electronic Co.,Ltd ,

Posted on